Abstract
Determination of pituitary thyroid-stimulating hormone (TSH) is one of the most common tests in the world. The article examines the variability of the TSH level in the blood and its causes in the context of the reliability of the assessment of this indicator. The defi nition of the term of subclinical hypothyroidism, namely the level of TSH that should be the reason for prescribing thyroxine, is also discussed. Most authors today believe that, in general, when hypothyroidism is fi rst detected, the appointment of thyroxine is mostly required only when TSH >10 mU/L. The purpose of the study: to reveal the degree of discrepancies between two TSH measurements with an interval of no more than 7 days. The research materials were the results of repeated measurements of TSH (measured in mU/L) of patients for the period 2000-2023. A total of 316 such pairs of TSH measurements (with an interval of no more than a week) were found in the electronic register. Cases where the interval between measurements was 6, 5, 4, and 3 days were also analyzed. At the same time, there were 104 pairs of measurements with an interval of 3 days. Results and discussion. The majority of cases are within the TSH discrepancy of up to 10 mU/L, but a signifi cant number of diff erences between the two TSH measurements are greater than 10 mU/L, and may even reach more than 100 mU/L. It was established that there is no dependence on the time interval between two measurements, the age of the patient, as well as no correlation of the diff erence in TSH measurements with the year of measurement (2000-2023). We believe that discrepancies in TSH measurements within several days fi rst of all arise due to the presence of circadian rhythms, the pulsating nature of the secretion and the infl uence of external factors (diff erent time of sampling, availability of breakfast, etc.). Conclusions. The fi rst detected result of TSH outside the normal range should not be the basis for diagnosis of hypothyroidism and prescribing treatment, except for cases when it fully corresponds to clinical signs and urgent treatment is necessary to improve the patient's condition. If there is a discrepancy between the TSH result and the clinical picture, it is desirable to check the results in diff erent laboratories, determine free triiodothyronine and thyroxine. In any clinical cases, you should not try to maintain TSH within the narrow limits of few units, because the actual fl uctuations during measurement are greater, which makes such eff orts useless.
References
Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, azvi S, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013 Dec;2(4):215-28. doi: 10.1159/000356507.
Andersen S, Karmisholt J, Bruun NH, Riis J, Noahsen P, Westergaard L, et al. Interpretation of TSH and T4 for diagnosing minor alterations in thyroid function: a comparative analysis of two separate longitudinal cohorts. Thyroid Res. 2022 Oct 10;15(1):19. doi: 10.1186/s13044-022-00137-1.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011 Oct;21(10):1081-125. doi: 10.1089/thy.2011.0087.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar;27(3):315-89. doi: 10.1089/thy.2016.0457.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and diff erentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and diff erentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
Sheehan MT. Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed – a review for primary care. Clin Med Res. 2016 Jun;14(2):83-92. doi: 10.3121/cmr.2016.1309.
Martínez M, Soldevila B, Lucas A, Velasco I, Vila L, Puig-Domingo M. Hypothyroidism during pregnancy and its association to perinatal and obstetric morbidity: a review. Endocrinol Diabetes Nutr (Engl Ed). 2018 Feb;65(2):107-13. English, Spanish. doi: 10.1016/j.endinu.2017.11.009.
Korevaar TIM. The upper limit for TSH during pregnancy: why we should stop using fi xed limits of 2.5 or 3.0 mU/l. Thyroid Res. 2018 May 21;11:5. doi: 10.1186/s13044-018-0048-7.
Lemieux P, Yamamoto JM, Nerenberg KA, Metcalfe A, Chin A, Khurana R, et al. Thyroid laboratory testing and management in women on thyroid replacement before pregnancy and associated pregnancy outcomes. Thyroid. 2021 May;31(5):841-9. doi: 10.1089/thy.2020.0609.
Yamamoto JM, Metcalfe A, Nerenberg KA, Khurana R, Chin A, Donovan LE. Thyroid function testing and management during and after pregnancy among women without thyroid disease before pregnancy. CMAJ. 2020 Jun 1;192(22):E596-E602. doi: 10.1503/cmaj.191664.
Pearce EN. Management of hypothyroidism and hypothyroxinemia during pregnancy. Endocr Pract. 2022 Jul;28(7):711-8. doi: 10.1016/j.eprac.2022.05.004.
Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory fi ndings, not for simple TSH elevation. Prescrire Int. 2015 Oct;24(164):241-4, 246.
Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019 May 14;365:l2006. doi: 10.1136/bmj.l2006. 14. Brito JP, Ross JS, El Kawkgi OM, Maraka S, Deng Y, Shah ND, et al. Levothyroxine use in the United States, 2008-2018. JAMA Intern Med. 2021 Oct 1;181(10):1402-5. doi: 10.1001/jamainternmed.2021.2686.
Wilson SA, Stem LA, Bruehlman RD. Hypothyroidism: diagnosis and treatment. Am Fam Physician. 2021 May 15;103(10):605-13.
